newsfilter
← Latest News
Business Wire·

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major